会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 62. 发明申请
    • VASCULAR TISSUE ENHANCEMENT AND SELECTIVE DESTRUCTION OF CANCEROUS CELLULAR TISSUE
    • 血管组织增强和选择性破坏癌细胞组织
    • WO2007149103A2
    • 2007-12-27
    • PCT/US2006025443
    • 2006-06-28
    • KAISER DANIEL E
    • KAISER DANIEL E
    • A61B19/00
    • A61H9/005A61B17/1128A61B17/22A61B17/2251A61B2017/00535A61B2017/00561A61B2017/00911A61B2017/22001A61H9/0057A61H2201/5082A61H2201/5087A61H2201/5089A61H2205/06A61H2205/083A61H2205/10
    • An apparatus for delivering decompressive energy to soft tissues to stimulate cellular expansion through deep penetration of said applied decompressive energy to said soft tissues to stimulate a predetermined reaction to application of said decompressive energy comprising a vessel having an open end and adapted to encompass the soft tissue to be stimulated. A source of decompressive energy in communication with said vessel and a flexible mass affixed to said open end of said vessel to absorb the pressure exerted by delivery of said decompressive energy to said soft tissue, thereby acting as a seal and force diffuser between said vessel and the soft tissue adjacent the periphery of said vessel. A method for the treatment of peripheral vascular disease (PVD) and other medical disorders and ailments that would benefit from increased and enhanced tissue response due to increases in blood flow on macro-vascular, micro-vascular and a collateral level including increased cellular stimulation and response. The method works by surrounding said tissues with a vessel or dome configured to fit over the tissue for treatment with decompressive energy (vacuum forces). The decompressive energy is applied in a controlled manner at a pre-selected level of decompressive force thereby increasing blood flow through the treated tissue. Loading forces generated by applied decompressive energy and the resulting forces generated between the interior of the vessel and the treated tissue which the vessel encompasses are diffused. A method and apparatus for applying decompressive energy to tissue for the selective destruction of cancerous cells is disclose and claimed. The tissue to be treated is enclosed within a vessel subjected to decompressive energy supplied by said decompressive energy source to said vessel. The decompressive energy is applied in a controlled manner to said tissue in at a pre-selected level of decompressive energy. Loading forces generated by applied decompressive energy and the forces generated between the interior of said vessel and said tissue which said vessel encompasses are to be diffused. As disclosed and claimed, a mass of elastic material comprising an inner radius and outer radius with the inner radius forming a seal with said tissue while allowing said tissue to move in relation to said inner radius and a fluid pocket circumf erentially positioned within said elastic mass in combination with a collar positioned at the perimeter of the vessel opening is claimed.
    • 一种用于向软组织递送减压能量以通过将所述施加的减压能量深入渗透到所述软组织来刺激细胞扩张的装置,以刺激施加所述减压能量的预定反应,所述减压能量包括具有开口端的容器并且适于包围软组织 被刺激。 与所述容器连通的减压能量源和固定在所述容器的所述开口端的柔性块,以吸收通过将所述减压能量递送到所述软组织而施加的压力,由此用作所述容器和 所述软组织邻近所述容器的周边。 一种用于治疗外周血管疾病(PVD)和其他医学疾病和疾病的方法,其将受益于由于血管,微血管和附属水平的血流增加而增加和增强的组织反应,包括增加的细胞刺激和 响应。 该方法通过用构造成适合于组织上的血管或圆顶围绕所述组织进行工作,以用减压能(真空力)进行治疗。 减压能量以受控的方式以预选的减压力水平施加,从而增加经过处理的组织的血液流量。 通过施加的减压能量产生的装载力和在容器内部和容器所包括的经处理的组织之间产生的所产生的力被扩散。 公开并要求保护用于将选择性破坏癌细胞的减压能量应用于组织的方法和装置。 要处理的组织被包封在经受由所述减压能源供应给所述容器的减压能量的容器内。 减压能量以受控的方式以预先选择的减压能量水平施加到所述组织。 通过施加的减压能量产生的装载力和在所述容器的内部和所述容器所包围的所述组织之间产生的力将被扩散。 如所公开和要求保护的,包括内半径和外半径的弹性材料块,其中内半径与所述组织形成密封,同时允许所述组织相对于所述内半径移动,并且周向地定位在所述弹性质量块内的流体袋 与位于容器开口的周边的套环组合。
    • 66. 发明申请
    • CHANNELED ENDOMURAL THERAPY
    • 通道内膜治疗
    • WO2007047368A9
    • 2007-06-21
    • PCT/US2006039891
    • 2006-10-13
    • ENDOLUMINAL THERAPEUTICS INCSLEPIAN MARVIN J
    • SLEPIAN MARVIN J
    • A61B17/22A61B17/00A61B17/88A61B18/24A61F2/958
    • A61B17/3207A61B17/00491A61B17/12022A61B17/12186A61B17/1219A61B17/12195A61B17/22A61B18/24A61B2017/00247A61B2017/1205A61B2017/22077A61B2018/00392A61K35/545
    • Diseases, aging, trauma, environmental exposure, infection and other events or agents can alter tissue function. In one embodiment, treatment is provided by therapeutically altering tissue function. This may be by continuing normal tissue function, suppressing tissue function, or enhancing tissue function. In a preferred embodiment, this treatment is effectuated by penetrating an organ, organ component or tissue structure and placing a supplemental material in a newly created space. This space is generally referred to herein as a "privileged space", i.e. a space not otherwise present in native tissue. Supplemental materials can be deposited and secured within the zone. Supplemental materials include materials forming barriers, supports, and/or materials that deliver agents having a pharmacologic, biochemical, or physiologic effect in vivo. Suitable supplemental materials include polymeric and non-polymeric materials, pharmacologic agents, cells, tissue fragments, microorganisms, viral agents, or other reagents modifying tissue function. The supplemental material is typically in the form of a reservoir/depot, or continuous or discontinuous layer. In one embodiment, supplemental materials, and methods of use thereof, are provided for the continuous or discontinuous therapy of defined regions of an organ, organ component or tissue structure. The supplemental materials may be delivered directly to any one or more of the three zones, endoluminal (or ectomural, for solid organs), endomural, or ectoluminal, of organs, organ components, or tissue structures. The supplemental materials can include natural or synthetic polymeric materials that are biodegradable or non-biodegradable. The supplemental materials can also contain bioactive agents to effectuate a change in an organ or organ component in need thereof. For example, agents that result in a reduced/hyponormal response or an amplified/hypernormal response may be included in the supplemental materials.
    • 疾病,老化,创伤,环境暴露,感染等事件或药剂可改变组织功能。 在一个实施方案中,通过治疗性改变组织功能来提供治疗。 这可能是通过持续正常的组织功能,抑制组织功能或增强组织功能。 在优选的实施方案中,通过穿透器官,器官组分或组织结构并将补充材料放置在新创建的空间中来实现该治疗。 该空间在本文中通常被称为“特权空间”,即在天然组织中不存在的空间。 补充材料可以在区域内沉积并固定。 补充材料包括形成屏障,载体和/或递送在体内具有药理学,生物化学或生理学作用的物质的材料。 合适的补充材料包括聚合物和非聚合材料,药理学试剂,细胞,组织碎片,微生物,病毒试剂或修饰组织功能的其他试剂。 补充材料通常是储存器/储存器或连续或不连续层的形式。 在一个实施方案中,提供补充材料及其使用方法用于器官,器官组分或组织结构的限定区域的连续或不连续治疗。 补充材料可以直接递送到器官,器官成分或组织结构的内腔(或体外,对于固体器官),内膜或体腔内的三个区域中的任何一个或多个。 补充材料可以包括可生物降解或不可生物降解的天然或合成聚合材料。 补充材料还可以含有生物活性剂以实现有需要的器官或器官成分的变化。 例如,可以在补充材料中包括导致减少/低反应或者放大/超正常反应的药剂。